The company ranks #1487 on Inc.’s list of America’s fastest-growing private companies with a three-year revenue growth of over 300% COLORADO SPRINGS, Colo., Aug. 15, 2023 /PRNewswire/ — Professional Transition Strategies (PTS), a company that facilitates dental practice purchases and…
The story of Q32 Bio, a company that develops therapeutics for inflammatory and autoimmune diseases, started two decades ago. That’s when V. Michael Holers, MD, a University of Colorado School of Medicine professor with a […]
Imagine a jigsaw puzzle with thousands of tiny pieces spread across a table. The puzzle’s completion promises insights into better personalized patient care, but the pieces are from different puzzle-makers – their sides not fully […]
BOULDER, Colo.–(BUSINESS WIRE)–Edgewise Therapeutics, Inc., (NASDAQ: EWTX), a clinical-stage biopharmaceutical company focused on developing orally bioavailable, small molecule therapies for the treatment of rare muscle disorders, announced today positive 4-month interim results from the ongoing […]
Copyright © 2026 Biotech Networks
